Home>>Signaling Pathways>> Tyrosine Kinase>> VEGFR>>Tivozanib (AV-951)

Tivozanib (AV-951)

Catalog No.GC12036

Tivozanib (AV-951; KRN951) is a potent and selective and orally active VEGFR tyrosine kinase inhibitor with IC50是of 0.21, 0.16, 0.24 nM for VEGFR-1, VEGFR-2, VEGFR-3, respectively. Tivozanib inhibits angiogenesis and vascular permeability in tumor tissues and shows antitumor activity. Tivozanib has the potential for the research of metastatic renal cell carcinoma (RCC) .

Products are for research use only. Not for human use. We do not sell to patients.

Tivozanib (AV-951) Chemical Structure

Cas No.: 475108-18-0

Size Price Stock Qty
10mM (in 1mL DMSO)
$64.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Protocol Chemical Properties Product Documents Related Products

Reviews

Review for Tivozanib (AV-951)

Average Rating: 5 ★★★★★ (Based on Reviews and 32 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Tivozanib (AV-951)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.